Vyome Holdings, Inc
Public company- Headquarters
- SAN CLEMENTE, California
- Ticker
- HIND
- CIK
- 0001427570
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOJerry Leonard | Aug 28, 2026 | Appointed |
| CFORobert Dickey | Aug 28, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive appointment
CFO appointed: Jerry Leonard
Jerry Leonard was named Chief Financial Officer of Vyome Holdings, Inc, effective September 1, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 28, 2026Role: Chief Financial Officer
- Executive departure
CFO departs: Robert Dickey
Robert Dickey, Interim Chief Financial Officer of Vyome Holdings, Inc, resigns the role, effective August 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 28, 2026Role: Interim Chief Financial Officer
Last verified Nov 8, 2026